What is the long-term trend for Core Laboratories's continuing operations (in dollars per share)?

Over 4 years (2021 to 2025), Core Laboratories's continuing operations (in dollars per share) has grown at a 10.2% compound annual growth rate (CAGR), from $0.44 to $0.65.

Core Laboratories CLB Continuing operations (in dollars per share)

Continuing operations (in dollars per share) at other companies

TE ConnectivityTEL

$2.92+7,200%

Monster BeverageMNST

$0.58+28.9%

Keysight TechnologiesKEYS

$1.26+42.8%

Dominion EnergyD

$0.69-10.4%

CortevaCTVA

-$0.46+39.5%

Advanced Micro DevicesAMD

$0.84+90.9%

Other financials

Income statement

See full

Revenue$121.8M-1.4%

Operating income$1.9M-57.3%

Net income-$789.0K-412%

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$22.8M+3.2%

Total debt$167.8M-6.8%

Total equity$268.9M+6.1%

Total assets$587.7M+0.3%

Cash flow

See full

Operating cash flow$4.0M-40.5%

CapEx$3.4M+23.8%

Free cash flow$517.0K-86.7%

Valuation

See full

Market cap$492.77M-9.3%

Enterprise value$637.8M-7.6%

P/E17×-1.4×

P/S0.9×-0.1×

Profitability

See full

Operating margin10.3%-0.2pp

Net margin5.5%+0.1pp

FCF margin4.3%-4.6pp

Returns & leverage

See full

Return on equity11.1%-0.4pp

Debt / equity0.6×-0.1×

Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerBasicShare.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's continuing operations (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Core Laboratories's continuing operations (in dollars per share)?: Core Laboratories (CLB) reported continuing operations (in dollars per share) of -$0.02 in Q1 2026.
What is the long-term trend for Core Laboratories's continuing operations (in dollars per share)?: Over 4 years (2021 to 2025), Core Laboratories's continuing operations (in dollars per share) has grown at a 10.2% compound annual growth rate (CAGR), from $0.44 to $0.65.